HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 36 | 43 | 83.7% | |
| HF 4 | 2011 | 35 | 40 | 87.5% | |
| HF 4 | 2012 | 42 | 49 | 85.7% | |
| HF 4 | 2013 | 50 | 54 | 92.6% | |
| HF004(S) | 2014 | 20 | 20 | 100.0% | |
| HF004(S) | 2015 | 18 | 20 | 90.0% | |
| HF004(S) | 2016 | 23 | 25 | 92.0% |
